期刊文献+

应用RNA干扰技术阻断PC-3细胞中SRC-1基因表达的意义 被引量:2

Inhibition of Survivin Gene Expression in PC-3 Cells by RNAi
原文传递
导出
摘要 目的:探讨RNA干扰技术沉默SRC-1基因后对PC-3细胞生长及侵袭性的影响。方法:将设计好的siRNA,用脂质体法转染PC-3细胞,通过Q-PCR、蛋白免疫印迹检测SRC-1的表达变化,并用CCK-8法检测细胞生长情况,用transwell小室检测PC-3细胞侵袭力。结果:转染SRC-1siRNA24小时后的前列腺癌PC-3细胞系中SRC-1mRNA的相对表达量下降约42%,48小时后下降约79%,差异具有统计学意义(P<0.05);转染24小时、48小时后PC-3细胞SRC-1蛋白的表达量(24h 0.5536±0.071、48h 0.3419±0.025)与阴性对照组(24h 0.8562±0.092、48h 0.8791±0.076)、转染试剂组(24h 0.7992±0.072、48h 0.9731±0.051)和空白对照组(24h 0.8375±0.054、48h 0.8826±0.043)相比明显减少(P<0.05)。在转染24小时、48小时、72小时、96小时后PC-3细胞生长情况(吸光度A值:24h 0.324±0.0252、48h 0.689±0.0141、72h 1.0032±0.0166、96h 1.4650±0.0327)与阴性对照组(24h 0.3216±0.0152、48h 0.7014±0.017、72h 0.9902±0.0272、96h 1.4596±0.0141)、转染试剂组(24h 0.3222±0.0343、48h 0.6904±0.0301、72h 0.993±0.0383、96h 1.4574±0.0464)和空白对照组(24h 0.3316±0.0192、48h0.7092±0.0265、72h 1.0136±0.0130、96h 1.4596±0.0128)比较没有明显变化(P>0.05),但是PC-3细胞的侵袭能力明显下降,干扰实验组的细胞(38±9.01)与阴性对照组(83.33±10.78)、转染试剂组(83.67±10.016)及空白对照组(84.67±11.24)相比较,穿过小室膜的细胞数量明显减少(P<0.05)。结论:siRNA有效地阻断了PC-3细胞中SRC-1基因的表达,SRC-1基因在mRNA和蛋白水平上的表达明显下调(P<0.01),并使转染后的PC-3细胞的侵袭能力下降,但转染后PC-3细胞生长无明显变化。 Objective: Design the siRNA based on the base sequences and transfect the PC-3 cell line for inhibiting the human SRC-1 gene by RNA interference, and to detect the effect of the silenced SRC-1 gene on PC-3 cells. Meth- ods: The PC-3 cells were transfected with the siRNA and the interference effect was detected by Q--PCR, Western blot. The proliferation of the PC-3 cells was detected by CCK-8 method and their invasion ability was detected by using transwell. Results: The expression of SRC-1 in transfected PC-3 cells was dropped by up to 42% after 24 hours and 79% after 48 hours at mRNA levels as compared with un-treated groups. After transfecting 24 to 48 hours, the expression of SRC-1 protein(24h 0. 5536 ± 0. 071 48h 0. 3419 ± 0. 025 )was markedly depressed in PC-3 cells as compared with negative control groups(24h 0. 8562 ± 0. 092 48h 0. 8791 ± 0. 076) ,transfection reagent groups (24h 0. 7992 ± 0. 072 48h 0. 9731 ± 0. 051 )and an-treated groups(24h 0.8375 ±0. 054 48h 0. 8826 ±0. 043). After transfecting 24 to 96 hours,the growth of the PC-3 cells ( absorbance value A : 24h 0. 324 ± 0. 0252, 48h 0.689 ± 0. 0141 72h 1. 0032 ± 0. 0166,96h 1. 4650 ± 0. 0327)was not significantly different when compared with negative control groups(24h 0. 3216 ±0. 0152, 48h 0. 7014 ±0. 017,72h 0. 9902 ± 0. 0272,96h 1. 4596 ± 0. 0141 ),transfection reagent groups (24h 0. 3222 ± 0. 0343,48h 0.6904 ± 0.0301,72h 0. 993 ± 0. 0383,96h 1. 4574 ± 0. 0464) and un-treated groups(24h 0. 3316 ±0. 0192,48h 0. 7092 ±0. 0265,72h 1. 0136 ±0. 0130,96h 1. 4596 ±0. 0128). Furthermore, the PC-3 cells were observed along with a marked inhibition of invasion as reflected by fewer penetrating cells by hoyden ehamber assay(38 ± 9.01 ), compared with negative control groups(83.33 ± 10.78) ,transfeefion reagent groups ( 83.67 ± 10. 016 ) and un-treated groups ( 84.67 ± 11.24 ) with significant difference ( P 〈 0.05 ). Conclusion: After transfeetion, the expressions of SRC-1 gene were inhibited effectively and the invasion ability was reduced obviously by the siR- NA in the prostate cancer cell line PC-3.
出处 《肿瘤预防与治疗》 2013年第6期313-317,共5页 Journal of Cancer Control And Treatment
关键词 RNA干扰 SRC-1 侵袭性 PC-3细胞 RNA Interference SRC-1 Invasion Ability PC-3
  • 相关文献

参考文献13

  • 1Irina U,Ajula Vaid,William E. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression[J].{H}CANCER RESEARCH,2005,(17):7959-7967.
  • 2Pienta KJ,Bradley D. Mechanisms underlying the development of androgen-independent prostate cancer[J].{H}Clinical Cancer Research,2006,(06):1665-1671.
  • 3Gregory CW,Hamil KG,Kim D. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes[J].{H}Cancer Research,1998,(24):5718-5724.
  • 4张艳,秦琴,周度金,陈彬,陈敏.核受体超家族及其辅调节子的研究进展[J].局解手术学杂志,2007,16(1):58-59. 被引量:11
  • 5于丹丹,孟和,李婧,白春艳,潘玉春.SRC-1/NCOA-1基因的研究进展[J].上海畜牧兽医通讯,2006(3):2-3. 被引量:1
  • 6Xu J,Qiu Y,DeMayo FJ. Partial hormone resistance in mice with disruption ofthe steroid receptor coactivator-1 (SRC-1) gene[J].{H}SCIENCE,1998,(5358):1922-1925.
  • 7Gregory CW,He B,Johnson RT. A mechanism forandrogen receptor-mediated prostate cancer recurrence after androgen deprivation therapy[J].{H}CANCER RESEARCH,2001,(11):4315-4319.
  • 8甘道举,江军,陈善勤,赖建平,孙广运,肖华亮,靳风烁.类固醇受体辅活化子-1和核受体辅阻遏子在雄激素非依赖性前列腺癌的表达及临床意义[J].现代泌尿外科杂志,2006,11(3):138-140. 被引量:2
  • 9Fujiraoto N,Mizokami A,Harada S. Different expression of androgen receptor coaetivators in human prostate[J].{H}UROLOGY,2001,(02):289-294.
  • 10文航,章宜芬,管杨波,杨军,戴玉田.雄激素受体辅调节因子在前列腺癌内分泌治疗中的预测意义[J].中国肿瘤临床,2010,37(8):448-451. 被引量:2

二级参考文献57

  • 1李守业,陈昂,胡滨.晚期前列腺癌骨转移的综合性治疗[J].中国肿瘤临床,2006,33(1):52-54. 被引量:2
  • 2杨全成,徐勇,李凯,张晓光,牛远杰.263例前列腺癌患者诊断治疗现状[J].中国肿瘤临床,2006,33(6):339-341. 被引量:11
  • 3Koivisto P,Kolmer M,Visakorpi T,et al.Androgen receptor gene and hormonal therapy failure of prostate cancer[J].Am J Pathol,1998,152(1):1-9.
  • 4Devlin HL,Mudryj M.Progression of prostate cancer:multiple pathways to androgen independence[J].Cancer Lett,2009,274(2):177-186.
  • 5Edwards J,Bartlett JM.The androgen receptor and signal-trans-duction pathways in hormone-refractory prostate cancer.Part 1:Modifications to the androgen receptor[J].BJU Int,2005,95(9):1320-1326.
  • 6Edwards J,Bartlett JM.The androgen receptor and signal-trans-duction pathways in hormone-refractory prostate cancer.Part 2:Androgen-receptor cofactors and bypass pathways[J].BJU Int,2005,95(9):1327-1335.
  • 7Gregory CW,He B,Johnson RT,et al.A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy[J].Cancer Res,2001,61(11):4315-4319.
  • 8Fujimoto N,Mizokami A,Harada S,et al.Different expression of androgen receptor coactivators in human prostate[J].Urology,2001,58(2):289-294.
  • 9Fleming FJ,Hill AD,McDermott EW,et al.Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hy-droxytamoxifen in human breast cancer[J].J Clin Endocrinol Metab,2004,89(1):375-383.
  • 10Myers E,Fleming FJ,Crotty TB,et al.Inverse relationship between ER-beta and SRG-1 predicts outcome in endocrine-resistant breast cancer[J].BrJ Cancer,2004,91(9):1687-1693.

共引文献12

同被引文献5

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部